Todd Bazemore Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd Bazemore.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd Bazemore. Todd Bazemore is a EVP & Chief Commercial Officer in DYAX CORP ($DYAX) and a Chief Operating Officer in Kala Pharmaceuticals, Inc. ($KALA) and a Director in Pulmatrix, Inc. ($PULM).
Address: C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON 01803 MA
Companies in which Todd Bazemore is an Insider
DYAX CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Todd Bazemore: EVP & Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Jan 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kala Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd Bazemore: Chief Operating Officer
Holdings: 137,500 shares
Latest Transaction: Jan 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pulmatrix, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd Bazemore: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 01 2021
$PULM Market Capitalization: $73.21M
$PULM Previous Close: $4.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Todd Bazemore
Sentiment: All, DYAX, KALA, PULM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | PULM | Pulmatrix, Inc. | Bazemore Todd | Director | Option Exercise | A | 1.47 | 15,000 | 22,050 | 15,000 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Option Exercise | A | 6.86 | 110,000 | 754,600 | 110,000 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Option Exercise | A | 6.86 | 110,000 | 754,600 | 110,000 | |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Grant | A | 0.00 | 27,500 | 0 | 137,500 | 110 K to 137.5 K (+25.00 %) |
| Jan 05 2021 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Grant | A | 0.00 | 27,500 | 0 | 137,500 | 110 K to 137.5 K (+25.00 %) |
| Oct 28 2020 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Buy | P | 7.60 | 40 | 304 | 42 | 2 to 42 (+2,000.00 %) |
| Oct 28 2020 | KALA | Kala Pharmaceutica ... | Bazemore Todd | Chief Operating Off ... | Buy | P | 13.39 | 2 | 27 | 2 | 0 to 2 |